CAJ | 학술논문

目的：探讨影响肝门部胆管癌的预后因素。方法回顾性分析2006年1月至2009年1月47例肝门部胆管癌患者的临床资料，分析肝门部胆管癌的预后影响因素。结果全组患者的1年生存率为63.6%，3年生存率为18.2%，5年生存率为6.8%。Cox 回归模型分析显示肿瘤分期和局部浸润与转移是影响肝门部胆管癌患者预后的独立风险因素。结论肝门部胆管癌的预后与肿瘤分期和局部浸润与转移密切相关，选择适宜的治疗方式，有望获得良好的近远期治疗效果。
목적：탐토영향간문부담관암적예후인소。방법회고성분석2006년1월지2009년1월47례간문부담관암환자적림상자료，분석간문부담관암적예후영향인소。결과전조환자적1년생존솔위63.6%，3년생존솔위18.2%，5년생존솔위6.8%。Cox 회귀모형분석현시종류분기화국부침윤여전이시영향간문부담관암환자예후적독립풍험인소。결론간문부담관암적예후여종류분기화국부침윤여전이밀절상관，선택괄의적치료방식，유망획득량호적근원기치료효과。
Objective To investigate the prognosis factors of hilar cholangiocarcinoma(HCC). Methods The clinical data were retrospectively analyzed in 47 cases of hilar cholangiocarcinoma admitted into our hospital from Jan. 2006 to Jan. 2009. Results Of 47 cases with hilar cholangiocarcinoma,1-year survival,3-year sur-vival and 5-year survival were 63. 6% ,18. 2% and 6. 8% . Cox regression analysis showed that TNM stage and distant metastases were the dependent prognosis factors,while the age,gender,Bismuth-Corlette type,TBIL before operation,CA19-9 level were not the dependent prognosis factors. Conclusions The prognosis of hilar cholangiocarcinoma correlates with clinical stage and distant metastases. Choosing an appropriate treatment can achieve a better short-term and long-term outcomes.